Catalent
CTLT
#1594
Rank
$10.70 B
Marketcap
$58.95
Share price
-0.08%
Change (1 day)
47.63%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.29

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.29. In 2022 the company made an earnings per share (EPS) of $2.27 a decrease over its 2021 EPS that were of $3.27.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.29-156.83%
2022$2.27-30.58%
2021$3.2779.67%
2020$1.82114.12%
2019$0.85-15%
2018$1.0075.44%
2017$0.57-22.97%
2016$0.74-59.56%
2015$1.83282.05%
2014$0.48-378.2%
2013-$0.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$0.79-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.75-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.41 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$6.39-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA